The Need for Prudence When Using 18F-FDG PET as a Reference Standard for Lymphoma Detection-Reference-Cited by-同舟云学术

The Need for Prudence When Using 18F-FDG PET as a Reference Standard for Lymphoma Detection

Published:2016-12-01 Issue:8 Volume:58 Page:1354-1355
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Adams Hugo J.A.,Kwee Thomas C.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference10 articles.

1. Comparison of 11C-Methionine and 18F-FDG PET/CT for Staging and Follow-up of Pediatric Lymphoma

2. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography;Kubota;J Nucl Med.,1992

3. Dose-response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [18F]FDG PET

4. Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: systematic review and meta-analysis;Adams;Eur J Radiol.,2016

5. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma;Adams;Blood Rev.,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow infiltration by flow cytometry at diffuse large B‐cell lymphoma NOS diagnosis implies worse prognosis without considering bone marrow histology;Cytometry Part B: Clinical Cytometry;2019-12-24

2. [18F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [18F]FDG in human xenograft models;Theranostics;2018

3. Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma;Cancer Medicine;2017-09-27